Effects of a neurokinin-1 receptor antagonist in the acute phase after thoracic spinal cord injury in a rat model.

Frontiers in molecular neuroscience(2023)

Cited 2|Views5
No score
Abstract
Intrathecal administration of NRA might reinforce the integrity of the BSCB in the acute phase after SCI, potentially attenuating aspects of neurogenic inflammation, reducing edema formation, and improving functional recovery.
More
Translated text
Key words
spinal cord injury,animal model,neurokinin-1 (NK1) antagonist,blood spinal cord barrier,inflammation,behavioral assessment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined